. Troponin, * BUN refers to blood urea nitrogen; ALT, alanine aminotransferase; WBC, white blood cells count

R. 1. Puymirat, E. Simon, T. Steg, P. Schiele, F. Guéret et al., Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction, USIK USIC 2000 Investigators, FAST MI Investigators, pp.998-1006, 2012.
DOI : 10.1001/2012.jama.11348

G. Fröhlich, P. Meier, S. White, D. Yellon, and D. Hausenloy, Myocardial reperfusion injury: looking beyond primary PCI, European Heart Journal, vol.55, issue.23, pp.1714-1722, 2013.
DOI : 10.1016/j.jacc.2009.10.052

P. Christia and N. Frangogiannis, Targeting inflammatory pathways in myocardial infarction, European Journal of Clinical Investigation, vol.87, issue.9, pp.986-995, 2013.
DOI : 10.1161/01.CIR.87.2.526

F. Arslan, D. De-kleijn, L. Timmers, P. Doevendans, and G. Pasterkamp, Bridging Innate Immunity and Myocardial Ischemia/Reperfusion Injury: The Search for Therapeutic Targets, Current Pharmaceutical Design, vol.14, issue.12, pp.1205-1216, 2008.
DOI : 10.2174/138161208784246090

F. Arslan, D. De-kleijn, and G. Pasterkamp, Innate immune signaling in cardiac ischemia, Nature Reviews Cardiology, vol.182, issue.5, pp.292-300, 2011.
DOI : 10.4049/jimmunol.0803842

Y. Feng and W. Chao, Toll-Like Receptors and Myocardial Inflammation, International Journal of Inflammation, vol.169, issue.6, p.170352, 2011.
DOI : 10.1097/ALN.0b013e31820a4d78

A. Bouchon, F. Facchetti, M. Weigand, and M. Colonna, TREM-1 amplifies inflammation and is a crucial mediator of septic shock, Nature, vol.410, issue.6832, pp.1103-1107, 2001.
DOI : 10.1038/35074114

S. Gibot, M. Kolopp-sarda, M. Béné, P. Bollaert, A. Lozniewski et al., A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine Sepsis, The Journal of Experimental Medicine, vol.10, issue.11, pp.1419-1426, 2004.
DOI : 10.7326/0003-4819-141-1-200407060-00009

S. Gibot, C. Alauzet, F. Massin, N. Sennoune, G. Faure et al., Modulation of the Triggering Receptor Expressed on Myeloid Cells???1 Pathway during Pneumonia in Rats, The Journal of Infectious Diseases, vol.194, issue.7, pp.975-983, 2006.
DOI : 10.1086/506950

M. Derive, A. Boufenzer, Y. Bouazza, F. Groubatch, C. Alauzet et al., Effects of a TREM-Like Transcript 1???Derived Peptide During Hypodynamic Septic Shock in Pigs, Shock, vol.39, issue.2, pp.176-182, 2013.
DOI : 10.1097/SHK.0b013e31827bcdfb

URL : https://hal.archives-ouvertes.fr/hal-01272749

M. Derive, Y. Bouazza, N. Sennoun, S. Marchionni, L. Quogley et al., Soluble Trem-like Transcript-1 Regulates Leukocyte Activation and Controls Microbial Sepsis, The Journal of Immunology, vol.188, issue.11, pp.5585-5592, 2012.
DOI : 10.4049/jimmunol.1102674

URL : http://www.jimmunol.org/content/jimmunol/188/11/5585.full.pdf

K. Kamei, T. Yasuda, T. Ueda, F. Qiang, Y. Takeyama et al., Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis, Journal of Hepato-Biliary-Pancreatic Sciences, vol.187, issue.3, pp.305-312, 2010.
DOI : 10.1086/374754

S. Gibot, F. Massin, C. Alauzet, M. Derive, C. Montemont et al., EFFECTS OF THE TREM 1 PATHWAY MODULATION DURING HEMORRHAGIC SHOCK IN RATS, Shock, vol.32, issue.6, pp.633-637, 2009.
DOI : 10.1097/SHK.0b013e3181a53842

M. Schenk, A. Bouchon, F. Seibold, and C. Mueller, TREM-1???expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases, Journal of Clinical Investigation, vol.117, issue.10
DOI : 10.1172/JCI30602DS1

C. Collins, D. La, H. Yang, F. Massin, S. Gibot et al., Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.68, issue.11, pp.1768-1774, 2009.
DOI : 10.1136/ard.2008.089557

C. Bisson, F. Massin, P. Lefevre, N. Thilly, N. Miller et al., Increased gingival crevicular fluid levels of soluble triggering receptor expressed on myeloid cells (sTREM) -1 in severe periodontitis, Journal of Clinical Periodontology, vol.36, issue.53, pp.1141-1148, 2012.
DOI : 10.1097/CCM.0b013e31817b8824

R. Roberts, V. Demello, and B. Sobel, Deleterious effects of methylprednisolone in patients with myocardial infarction, Circulation, vol.53, pp.204-206, 1976.

K. Baran, M. Nguyen, G. Mckendall, C. Lambrew, G. Dykstra et al., Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study, Circulation, vol.104, issue.23, pp.2778-2783, 2001.
DOI : 10.1161/hc4801.100236

D. Faxon, R. Gibbons, N. Chronos, P. Gurbel, F. Sheehan et al., The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study, Journal of the American College of Cardiology, vol.40, issue.7, pp.1199-1204, 2002.
DOI : 10.1016/S0735-1097(02)02136-8

C. Granger, K. Mahaffey, W. Weaver, P. Theroux, J. Hochman et al., Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) Trial, Circulation, vol.108, issue.10, pp.1184-1190, 2003.
DOI : 10.1161/01.CIR.0000087447.12918.85

K. Mahaffey, C. Granger, J. Nicolau, W. Ruzyllo, W. Weaver et al., Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) Trial, Circulation, vol.108, issue.10, pp.1176-1183, 2003.
DOI : 10.1161/01.CIR.0000087404.53661.F8

A. Ami-investigators, P. Armstrong, C. Granger, P. Adams, C. Hamm et al., Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial, JAMA, vol.297, pp.43-51, 2007.

O. How, A. Røsner, A. Kildal, T. Stenberg, P. Gjessing et al., Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock, Translational Research, vol.156, issue.5, pp.273-281, 2010.
DOI : 10.1016/j.trsl.2010.07.011

F. Mccall, K. Telukuntla, V. Karantalis, V. Suncion, A. Heldman et al., Myocardial infarction and intramyocardial injection models in swine, Nature Protocols, vol.3, issue.8, pp.1479-1496, 2012.
DOI : 10.1016/S0735-1097(99)00126-6

R. Fincke, J. Hochman, A. Lowe, V. Menon, J. Slater et al., Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry, Journal of the American College of Cardiology, vol.44, issue.2, pp.340-348, 2004.
DOI : 10.1016/j.jacc.2004.03.060

R. Lefering and E. Neugebauer, Steroid controversy in sepsis and septic shock, Critical Care Medicine, vol.23, issue.7, pp.1294-1303, 1995.
DOI : 10.1097/00003246-199507000-00021

C. Fisher, J. Dhainaut, S. Opal, J. Pribble, R. Balk et al., Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group, JAMA: The Journal of the American Medical Association, vol.271, issue.23, pp.1836-1843, 1994.
DOI : 10.1001/jama.271.23.1836

A. Abbate, B. Van-tassell, G. Biondi-zoccai, M. Kontos, J. Grizzard et al., Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study], VCU-ART2) pilot study], pp.1394-1400, 2013.
DOI : 10.1016/j.amjcard.2013.01.287

M. Dirksen, G. Laarman, M. Simoons, and D. Duncker, Reperfusion injury in 98, J. Lemarié et al

N. Webster and H. Galley, Immunomodulation in the critically ill, British Journal of Anaesthesia, vol.103, issue.1, pp.70-81, 2009.
DOI : 10.1093/bja/aep128

T. Kempf, A. Zarbock, D. Vestweber, and K. Wollert, Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing, Journal of Molecular Medicine, vol.55, issue.4, pp.361-369, 2012.
DOI : 10.1016/j.jacc.2009.06.059

M. Derive, A. Boufenzer, and S. Gibot, Attenuation of Responses to Endotoxin by the Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor LR12 in Nonhuman Primate, Anesthesiology, vol.120, issue.4, pp.935-942, 2014.
DOI : 10.1097/ALN.0000000000000078

URL : https://hal.archives-ouvertes.fr/hal-01738448

W. Xiao, M. Mindrinos, J. Seok, J. Cuschieri, A. Cuenca et al., A genomic storm in critically injured humans, The Journal of Experimental Medicine, vol.61, issue.13, pp.2581-2590, 2011.
DOI : 10.1038/nature08780

M. Nahrendorf, F. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger et al., The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions, The Journal of Experimental Medicine, vol.52, issue.12, pp.3037-3047, 2007.
DOI : 10.1007/BF00788278

URL : http://europepmc.org/articles/pmc2118517?pdf=render

J. Jordan, Z. Zhao, and J. Vinten-johansen, The role of neutrophils in myocardial ischemia???reperfusion injury, Cardiovascular Research, vol.43, issue.4, pp.860-878, 1999.
DOI : 10.1016/S0008-6363(99)00187-X

H. Jaeschke and C. Smith, Mechanisms of neutrophil-induced parenchymal cell injury, Journal of Leukocyte Biology, vol.61, issue.6, pp.647-653, 1997.
DOI : 10.1002/jlb.61.6.647

S. Tavener, E. Long, S. Robbins, K. Mcrae, H. Van-remmen et al., Immune Cell Toll-Like Receptor 4 Is Required for Cardiac Myocyte Impairment During Endotoxemia, Circulation Research, vol.95, issue.7, pp.700-707, 2004.
DOI : 10.1161/01.RES.0000144175.70140.8c

V. Braunersreuther and V. Jaquet, Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches, Current Pharmaceutical Biotechnology, vol.13, issue.1, pp.97-114, 2012.
DOI : 10.2174/138920112798868782

G. Blaudszun, M. Licker, and D. Morel, : a sensitive, continuous, load-independent contractility index, Experimental Physiology, vol.287, issue.10, pp.1446-1456, 2013.
DOI : 10.1152/ajpheart.00624.2003

URL : http://onlinelibrary.wiley.com/doi/10.1113/expphysiol.2013.073833/pdf